Loading clinical trials...
Loading clinical trials...
An Exploratory Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).
Conditions
Interventions
IVB103 Injection（Low dose）
IVB103 Injection（Intermediate dose）
+1 more
Locations
1
China
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Start Date
April 22, 2025
Primary Completion Date
December 31, 2027
Completion Date
December 31, 2031
Last Updated
April 30, 2025
NCT05407636
NCT07308639
NCT05562947
NCT06929143
NCT06075147
NCT04514653
Lead Sponsor
InnoVec Biotherapeutics Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions